Text Mining of Symptom Descriptions in the Vaccine Adverse Event Reporting System for Human Papillomavirus Vaccination

人乳头瘤病毒疫苗不良事件报告系统中症状描述的文本挖掘

阅读:1

Abstract

INTRODUCTION: The World Health Organizationhas reaffirmed the efficacy and safety of human papillomavirus (HPV) vaccines in a statement. While vaccine safety has been extensively studied, little is known about the descriptive language used in reports of adverse events. The Vaccine Adverse Event Reporting System (VAERS), managed by the US Food and Drug Administration and the Centers for Disease Control and Prevention, collects free-text narratives on adverse events following vaccination. This study aimed to examine these narratives to describe vocabulary patterns associated with HPV vaccination. METHODS: We conducted a retrospective, cross-sectional observational study using quantitative text mining techniques. Symptom descriptions related to HPV vaccination were extracted from the Vaccine Adverse Event Reporting System (VAERS, 2009-2023). Sentiment analysis was performed with the AFINN lexicon in R ("tidytext" package), which assigns numerical sentiment scores to words. This quantitative scoring approach enabled us to describe vocabulary patterns without qualitative inference of context or emotions. RESULTS: Sentiment analysis was performed using the R "tidytext" package with the AFINN lexicon. Reports on suspected adverse events were obtained from the VAERS reports spanning 2009 to 2023, comprising 55,919 suspected adverse events. Approximately 6% of these reports involved product handling issues. The analysis showed that sentiments toward vaccination were more negative among females than males. CONCLUSION: Healthcare providers supporting HPV vaccination should provide patients with accurate and comprehensive information on vaccine safety and potential adverse reactions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。